Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas

Brain Tumor Pathology

Volumn 31, Issue 1, 2014, Pages 1-10

  Cao, Wei Dong ^a,b   Kawai, Nobuyuki ^a   Miyake, Keisuke ^a   Zhang, Xiang ^b   Fei, Zhou ^b   Tamiya, Takashi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

14 3 3zeta; F; Glioma; HIF 1 ; VEG

Indexed keywords

14 3 3ZETA PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL TIME; VERY ELDERLY;

14-3-3 PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BRAIN NEOPLASMS; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84895899438     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-013-0135-3     Document Type: Article

References (30)

1. Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol Mech Dis 1:97-117
2. Louis DN, Ohgaki H, Wiestler OD (2007) WHO classification of tumors of the central nervous system, vol 1, 4th edn. IARC, Lyon
3. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93-108 (Pubitemid 40287792)
4. Rajendran JG, Mankoff DA, O'Sullivan F et al (2004) Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10:2245-2252 (Pubitemid 38445681)
5. Brat DJ, Castellano-Sanchez AA, Hunter SB et al (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920-927 (Pubitemid 38176893)
6. Fischer I, Gagner JP, Law M et al (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15: 297-310 (Pubitemid 41677429)
7. Tsang RW, Fyles AW, Milosevic M et al (2000) Interrelationship of proliferation and hypoxia in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 46:95-99 (Pubitemid 30021486)
8. Slomiany MG, Rosenzweig SA (2006) Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 318:666-675 (Pubitemid 44061241)
9. Cao WD, Zhang X, Zhang JN et al (2006) Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J Neurooncol 77:125-130 (Pubitemid 44419745)
10. Yang X, Cao W, Lin H et al (2009) Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci 276:54-59
11. Sunayama J, Tsuruta F, Masuyama N et al (2005) JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170:295-304 (Pubitemid 41043811)
12. Yang X, Cao W, Zhang L et al (2012) Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther 19:153-159
13. Neal CL, Xu J, Li P et al (2012) Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene 31:897-906
14. Karar J, Gerniglia GJ, Lindsten T et al (2012) Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translocation and increases cell death under hypoxia. Cancer Biol Ther 13:1102-1111
15. Lin YM, Huang YL, Fong YC et al (2012) Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway. PLoS One 7:e50924. doi:10.1371/journal.pone. 0050924
16. Remmele W, Hildebrand U, Hienz HA et al (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on estrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch 409:127-147 (Pubitemid 16084979)
17. Cao L, Cao W, Zhang W et al (2008) Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci Lett 432:94-99
18. Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:162-172
19. Berardi S, Caivano A, Ria R et al (2012) Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets. Oncogene 31:2258-2269
20. Kobayashi H, Ogura Y, Sawada M et al (2011) Involvement of 14-3-3 proteins in the second epidermal growth factor-induced wave of Rac1 activation in the process of cell migration. J Biol Chem 286:39259-39268
21. Oksvold MP, Huitfeldt HS, Langdon WY (2004) Identification of 14-3-3zeta as an EGF receptor interacting protein. FEBS Lett 569:207-210 (Pubitemid 38844619)
22. Cao W, Yang X, Zhou J et al (2010) Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 15:230-241
23. Yang X, Cao W, Zhou J et al (2011) 14-3-3zeta positive expression is associated with a poor prognosis in patients with glioblastoma. Neurosurgery 68:932-938
24. Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317-335
25. Kaur B, Khwaja FW, Severson EA et al (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134-153 (Pubitemid 40590514)
26. Oliver L, Olivier C, Marhuenda FB et al (2009) Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2:263-284
27. Mashiko R, Takano S, Ishikawa E et al (2011) Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image. J Neurooncol 102:43-50
28. Gillespie DL, Whang K, Ragel BT et al (2007) Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 13:2441-2448 (Pubitemid 46698595)
29. Argyriou AA, Giannopoulou E, Kalofonos HP (2009) Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Oncology 77:1-11
30. Machein MR, Plate KH (2000) VEGF in brain tumors. J Neurooncol 50:109-120 (Pubitemid 32166295)